DEFINITIVE PROXY STATEMENT

Company

AYTU BIOPHARMA, INC

Filed

May 9, 2018

Period of Report

June 27, 2018

Accession Number

0001213900-18-005782

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →